The MATTERHORN Phase III trial has demonstrated that a perioperative regimen combining AstraZeneca’s Imfinzi (durvalumab) with FLOT chemotherap ...

The company reported a robust set of numbers for the December quarter of FY25, with its profit nearly doubling year-on-year ...

Daiichi Sankyo and AstraZeneca’s Enhertu (trastuzumab deruxtecan) has shown clinically meaningful 'improvement' in the ...

Below, 112 Black-owned fashion brands to shop well beyond Black History Month. Happy shopping and supporting Black excellence! This brand brings a fun and fresh spin on classic wardrobe staples.

TOKYO & MUNICH - Daiichi Sankyo (TSE: 4568) and AstraZeneca (LSE/STO/Nasdaq: NASDAQ:AZN) have announced that their drug ENHERTU (trastuzumab deruxtecan) has been recommended for approval in the ...

As men’s embrace of jewelry has grown even more enthusiastic, the best men’s jewelry brands have evolved tremendously. Once confined to simple, utilitarian pieces, the best jewelry brands for ...

LONDON - AstraZeneca PLC (LON:AZN) and Daiichi Sankyo’s Enhertu has been recommended for approval by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA).

The European Union's health regulator on Friday backed AstraZeneca and Daiichi Sankyo's drug Enhertu as a breast cancer ...

Demandbase, the pioneer in account-based GTM for B2B enterprises, today announces it has been named a Leader in "The Forrester Wavetm: Intent Data Providers For B2B, Q1 2025." The Forrester report ...